RIVM withdraws from tobacco committees The Dutch National Institute for Public Health and the Environment will leave the NEN/CEN/ISO committees for tobacco and e-cigarettes with immediate effect.
RIVM advises on health risks after using make-up with asbestos RIVM was asked to give advice to the Human Environment and Transport Inspectorate in the Netherlands after asbestos was found in two make-up products.
Promotion: the interactions between the whooping cough bacteria and our immune system Today, Elise Hovingh will be awarded a PhD at Utrecht University with a thesis about whooping cough. She studied the interaction between the whooping cough bacteria and our immune system.
People who eat meat do not carry more ESBL bacteria RIVM research reveals that people who eat meat regularly do not carry ESBLs more frequently than vegetarians.
Historical research on reduction of childhood mortality due to vaccination To what extent has the National Vaccination Programme contributed to the prevention of disease and mortality since the beginning of the 20th century?
Need for adjustment authorisation for gene drive applications The National Institute for Public Health and the Environment (RIVM) advises to bring all gene drive applications under the authorisation requirement of the Dutch GMO legislation.
RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.
Breast milk as indicator of environmental pollutants The 6th worldwide study into Persistent Organic Pollutants (POPs) in breast milk is about to commence.
The National Immunisation Programme in the Netherlands: Developments in 2013 Annually RIVM provides an overview of key events and developments in the National Immunisation Programme (NIP).